Related Experiment Videos

Plasma proteins in children with trichuris dysentery syndrome

E S Cooper1, D D Ramdath, C Whyte-Alleng

  • 1Tropical Metabolism Research Unit, University of the West Indies, Kingston, Jamaica, West Indies.

Insights

Children with Trichuris trichiura dysentery show an acute phase response, including elevated fibronectin. Plasma viscosity remains high post-treatment, indicating persistent inflammation in trichuriasis.

Area of Science:

  • Clinical immunology
  • Parasitology
  • Pediatric infectious diseases

Background:

  • Trichuris trichiura infection, particularly dysentery syndrome (TDS), can cause significant health issues in children.
  • Understanding the systemic inflammatory response and plasma protein changes is crucial for managing TDS.

Purpose of the Study:

  • To investigate the systemic inflammatory response in children with Trichuris trichiura dysentery syndrome (TDS).
  • To characterize specific plasma protein disturbances in TDS compared to uninfected children within an endemic area.

Main Methods:

  • A cross-sectional study compared 53 children with TDS, 16 disease controls (DC), and 20 normal controls (NC).
  • Plasma levels of acute phase proteins (CRP, AAT, caeruloplasmin, albumin, globulin, fibrinogen, fibronectin, ferritin, transferrin) and plasma viscosity were measured.
  • Plasma viscosity was serially measured in TDS cases over six months.

Main Results:

  • TDS children exhibited significantly higher levels of C-reactive protein, alpha-1-antitrypsin, total globulin, fibronectin, and plasma viscosity compared to normal controls.
  • Disease controls also showed acute phase protein elevations, but increased caeruloplasmin was specific to this group.
  • An elevation in fibronectin was specific to the TDS group, and plasma viscosity remained elevated six months post-treatment.

Conclusions:

  • Intense Trichuris trichiura infection triggers an acute phase response.
  • Elevated plasma fibronectin is a specific marker in TDS.
  • Plasma viscosity remains abnormally high for at least six months after treatment in TDS patients.
Abstract

Related Concept Videos